Infertility Panel Centogene US, LLC - The Rare Disease Company
United States | 243 | 238 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
CentoNephro Plus Panel Centogene US, LLC - The Rare Disease Company
United States | 499 | 499 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Diabetes and Obesity Panel Centogene US, LLC - The Rare Disease Company
United States | 247 | 262 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Epilepsy Panel Centogene US, LLC - The Rare Disease Company
United States | 734 | 744 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Intellectual Disability Panel Centogene US, LLC - The Rare Disease Company
United States | 777 | 770 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Infertility Panel Centogene AG - the Rare Disease Company
Germany | 243 | 238 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Epilepsy Panel Centogene AG - the Rare Disease Company
Germany | 734 | 744 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Intellectual Disability Panel Centogene AG - the Rare Disease Company
Germany | 777 | 770 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
CentoNephro Plus Panel Centogene AG - the Rare Disease Company
Germany | 499 | 499 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Diabetes and Obesity Panel Centogene AG - the Rare Disease Company
Germany | 247 | 262 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Congenital Anomalies of the Gastrointestinal Tract Panel PreventionGenetics
United States | 297 | 180 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
VACTERL Association and Related Disorders Panel PreventionGenetics
United States | 123 | 84 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Congenital Diaphragmatic Hernia Panel PreventionGenetics
United States | 116 | 65 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Inherited Bone Marrow Failure Panel PreventionGenetics
United States | 266 | 186 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Lysosomal Storage Disorders Panel PreventionGenetics
United States | 242 | 146 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Medulloblastoma Panel PreventionGenetics
United States | 21 | 9 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Wilms Tumor Panel PreventionGenetics
United States | 48 | 28 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Pediatric Cancer Panel PreventionGenetics
United States | 78 | 64 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Hypospadias Panel PreventionGenetics
United States | 156 | 73 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Ambiguous Genitalia Panel PreventionGenetics
United States | 128 | 85 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
